Back

Beta-blockers remain a key treatment for the management of hypertrophic obstructive cardiomyopathy - discussion

31 August 2026 (14:45 - 15:15)
Organised by: Logo
Congress Presentation Part of: Great Debate: beta-blockers remain a key treatment for the management of hypertrophic obstructive cardiomyopathy Hypertrophic Cardiomyopathy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

2 More presentations in this session

Presentation thumbnail
Beta-blockers remain a key treatment for the management of hypertrophic obstructive cardiomyopathy: pro
Doctor C. Coats (Glasgow, GB)
Slides Video
Presentation thumbnail
Beta-blockers remain a key treatment for the management of hypertrophic obstructive cardiomyopathy: con
Doctor F. Dominguez (Madrid, ES)
Slides Video

Access the full session

Session thumbnail
Great Debate: beta-blockers remain a key treatment for the management of hypertrophic obstructive cardiomyopathy
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 14:45 CET
You may be interested in
thumbnail
Congress Presentation
No more beta-blockers for post-myocardial infarction patients with preserved left ventricular ejection fraction - discussion
31 August 2026
thumbnail
Congress Presentation
Myosin inhibitors in hypertrophic obstructive cardiomyopathy
30 August 2026
thumbnail
Congress Session
Ask the Trialists - MAPLE-HCM
30 August 2025
thumbnail
Congress Presentation
Patients with hypertrophic cardiomyopathy: should be restricted from sport - discussion
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources